TG Therapeutics to Host Conference Call on Second Quarter 2023 Financial Results and Business Update
July 31 2023 - 8:30AM
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a
conference call will be held on Tuesday, August 1, 2023, at 8:30 AM
ET to discuss results for the second quarter 2023 and provide a
business outlook for remainder of the year. Michael S. Weiss,
Chairman and Chief Executive Officer, will host the call.
In order to participate in the conference call,
please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the
U.S.), Conference Title: TG Therapeutics. A live webcast of this
presentation will be available on the Events page, located within
the Investors & Media section, of the Company's website at
www.tgtherapeutics.com. An audio recording of the conference call
will also be available for replay at www.tgtherapeutics.com, for a
period of 30 days after the call.
TG Therapeutics will announce its financial results
for this period in a press release to be issued prior to the
call.
ABOUT TG THERAPEUTICSTG
Therapeutics is a fully integrated, commercial stage,
biopharmaceutical company focused on the acquisition, development
and commercialization of novel treatments for B-cell diseases. In
addition to a research pipeline including several investigational
medicines, TG has received U.S. Food and Drug Administration (FDA)
approval for BRIUMVI® (ublituximab-xiiy), for the treatment of
adult patients with relapsing forms of multiple sclerosis (RMS), to
include clinically isolated syndrome, relapsing-remitting disease,
and active secondary progressive disease as well as European
Commission (EC) approval for BRIUMVI to treat adult patients with
RMS who have active disease defined by clinical or imaging
features. For more information, visit www.tgtherapeutics.com,
and follow us on Twitter @TGTherapeutics and on
LinkedIn.CONTACT:
Investor
Relations Email: ir@tgtxinc.comTelephone: 1.877.575.TGTX
(8489), Option 4
Media
Relations: Email: media@tgtxinc.com Telephone:
1.877.575.TGTX (8489), Option 6
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From Apr 2024 to May 2024
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From May 2023 to May 2024